-

CRISPR QC Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List

SAN DIEGO--(BUSINESS WIRE)--CRISPR QC is proud to announce that co-founder Kiana Aran has been recognized by Inc. magazine as a top 200 Female Founder. This prestigious list highlights women entrepreneurs who are making a significant impact in their respective industries and driving change.

Dr. Kiana Aran is a world-renowned bioengineer and innovator; she co-founded CRISPR QC with the mission to provide cutting-edge tools and technologies for CRISPR research and development. Dr. Aran is the inventor of the CRISPR-Chip, a groundbreaking technology that enables real-time, direct measurements of CRISPR activity that can advance sustainable agriculture and gene therapy development.

“As a female founder, I hope to inspire other women to have the courage and intellectual bravery to pursue their entrepreneurial goals,” says Dr. Aran. “The development of CRISPR-Chip technology has proven to be incredibly valuable for the CRISPR industry, and I am thrilled to see the impact of my work. This recognition from Inc. magazine is incredibly rewarding and motivates me to continue pushing boundaries in biotechnology innovations. I am excited to further bridge the gap between the benches in my academic lab and effective commercial applications.”

CRISPR QC congratulates Kiana Aran on this well-deserved recognition and looks forward to her continued leadership.

About CRISPR QC:

CRISPR QC provides innovative solutions for CRISPR research and development. The CRISPR-Chip is the core component of the CRISPR Analytics platform, which uniquely enables real-time, direct measurement of CRISPR activity. Our CRISPR Analytics Platform uses machine learning and data visualization to gain insights into gene editing and accelerate research. We strive to empower our customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by CRISPR editing.

About Inc:

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning, multiplatform content reaches more than 50 million people each month across a variety of channels, including websites, newsletters, social media, podcasts, and print. For more information, visit www.inc.com.

Contacts

Ross Bundy, President
CRISPR QC
858-285-4122
info@crisprqc.com

CRISPR QC


Release Versions

Contacts

Ross Bundy, President
CRISPR QC
858-285-4122
info@crisprqc.com

Social Media Profiles
More News From CRISPR QC

CRISPR QC Launches Three Innovative Products and Unveils Revamped Website

SAN DIEGO--(BUSINESS WIRE)--CRISPR QC, a pioneering biotechnology company in San Diego, is excited to announce the launch of several groundbreaking products designed to revolutionize the field of gene editing. These products, part of the CRISPR Analytics Platform, provide comprehensive insights into various stages of CRISPR workflows, enabling researchers to optimize their experiments with unparalleled accuracy. As CRISPR-based technologies advance, the need for interrogative data and effective...

Xcellerant Ventures Backs CRISPR QC in Series A and Commercial Expansion

SAN DIEGO--(BUSINESS WIRE)--CRISPR QC, a biotechnology start-up based in San Diego, is pleased to announce a major stride in its ongoing Series A funding round. Known for their CRISPR Analytics Platform, powered by the CRISPR-Chip, CRISPR QC analyzes and optimizes aspects of CRISPR editing before cell work, enabling researchers to save valuable time, money, and resources. The company has secured substantial funding from Xcellerant Ventures, a distinguished player in healthcare venture capital;...

Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity

SAN DIEGO--(BUSINESS WIRE)--Today, CRISPR QC announces that Paragraf, Ltd. has acquired Cardea Bio, the technology platform developer of the CRISPR-Chip - a graphene-based biosensor that powers CRISPR QC’s CRISPR Analytics Platform. Paragraf is the only company in the world to mass produce graphene electronics using transfer-free graphene and standard semiconductor processes, which ensures a reliable supply of CRISPR-chips for the CRISPR Analytics Platform, enabling it to meet the needs of the...
Back to Newsroom